Skip to main content
. 2016 Aug 8;8:149–155. doi: 10.2147/BCTT.S105563

Figure 2.

Figure 2

A diagram of CYP2D6, CYP3A5 polymorphisms, and breast cancer outcomes from previous research.

Abbreviations: TAM, tamoxifen; NDMT, N-desmethyl-tamoxifen; 4OHT, 4-hydroxy-tamoxifen; END, endoxifen; OS, overall survival; PFS, progress-free survival; CB, clinical benefit; IDFS, invasive disease-free survival; DFS, disease-free survival.